| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,567.10
|
|
Change (%)
|
71.70 (2.87%)
|
|
Best Buy (RS)
|
2569(x1)
|
|
Best Sell (RS)
|
2576.9(x4)
|
|
Today's Range (RS)
|
2,482.00
-
2,579.00
|
|
52-Week Range (RS)
|
794.00
-
2,699.00
|
|
Beta (1 Year)
|
0.45
|
|
|
|
|
|
| News |
|
Corporate Details |
| Fredun Pharmaceuticals to convene AGM |
| Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter |
| Board of Fredun Pharmaceuticals approves bonus issue of 2:1 |
| Board of Fredun Pharmaceuticals recommends final dividend |
| Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter |
| Fredun Pharmaceuticals to announce Quarterly Result |
| Fredun Pharmaceuticals sets up its 5th manufacturing unit in Palghar |
| Fredun Pharmaceuticals allots 40,000 equity shares on conversion of warrants |
| Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter |
| Fredun Pharmaceuticals to convene board meeting |
|
|
|
| Incoporation Year : 1987 |
| Chairman : Daulat N Medhora |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Fredun Pharmaceuticals Ltd
26 Manoj Industrial Premises,
G D Ambedkar Marg Wadala,
Mumbai,
Maharashtra-400031 |
Phone:91-22-40318111
Fax: |
| E-Mail : business@fredungroup.com |
| URL : http://www.fredungroup.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
16-Jun-2026 |
2532.75 |
-1.47 |
| 1Month |
25-May-2026 |
2384.10 |
4.67 |
| 3Month |
23-Mar-2026 |
1686.30 |
47.98 |
| 6Month |
23-Dec-2025 |
1716.20 |
45.40 |
| 1Year |
23-Jun-2025 |
819.35 |
204.56 |
|
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,506.90 |
-0.16 |
4,714.50 |
3,139.50 |
152,779.35 |
| Ajanta Pharma Ltd |
3,199.15 |
0.32 |
3,314.80 |
2,335.00 |
39,840.10 |
| Gland Pharma Ltd |
2,303.80 |
0.23 |
2,395.00 |
1,575.00 |
37,917.63 |
| Rubicon Research Ltd |
1,417.05 |
2.13 |
1,413.75 |
571.00 |
22,947.68 |
| ERIS Lifesciences Ltd |
1,456.80 |
-0.21 |
1,887.65 |
1,237.90 |
20,228.05 |
|
|
|
|